1 reports of this reaction
3.2% of all SALICYLIC ACID 17% WART REMOVER reports
#3 most reported adverse reaction
APHASIA is the #3 most commonly reported adverse reaction for SALICYLIC ACID 17% WART REMOVER, manufactured by AAA Pharmaceutical, Inc.. There are 1 FDA adverse event reports linking SALICYLIC ACID 17% WART REMOVER to APHASIA. This represents approximately 3.2% of all 31 adverse event reports for this drug.
Patients taking SALICYLIC ACID 17% WART REMOVER who experience aphasia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
APHASIA is moderately reported among SALICYLIC ACID 17% WART REMOVER users, representing a notable but not dominant share of adverse events.
In addition to aphasia, the following adverse reactions have been reported for SALICYLIC ACID 17% WART REMOVER:
The following drugs have also been linked to aphasia in FDA adverse event reports:
APHASIA has been reported as an adverse event in 1 FDA reports for SALICYLIC ACID 17% WART REMOVER. This does not prove causation, but indicates an association observed in post-market surveillance data.
APHASIA accounts for approximately 3.2% of all adverse event reports for SALICYLIC ACID 17% WART REMOVER, making it one of the most commonly reported side effect.
If you experience aphasia while taking SALICYLIC ACID 17% WART REMOVER, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.